Director Policy, Advocacy & Government Affairs (m/f/x) – Brussels & EU
ABOUT CSL
CSL is a leading global biotechnology company with a constantly evolving portfolio of lifesaving products, built from the company’s passion to always put patients and people first.
Headquartered in Melbourne and listed on the Australian Stock Exchange, CSL provides life-saving medicines in more than 60 countries and has over 32,000 employees worldwide. Innovation and growth is a priority for CSL, and its exceptional track record of year-on-year growth and shareholder return coupled with sustained patient impact have garnered CSL a strong reputation across its broad and diverse stakeholder base.
OUR CORE CSL BUSINESSES
CSL Behring's portfolio of innovative medicines includes a wide range of recombinant and plasma-derived products for treating bleeding disorders, immune deficiencies and chronic inflammatory demyelinating polyneuropathy, as well as hereditary angioedema and Alpha 1 Antitrypsin Deficiency.
CSL Plasma operates one of the world’s largest and most sophisticated plasma collection networks, with more than 300 plasma collection centers in U.S., Europe and China. Plasma collected at CSL Plasma facilities are used by CSL Behring for the purpose of manufacturing and delivering its life-saving therapies to people in more than 100 countries.
CSL Seqirus was established in 2015 from the joining of bioCSL, CSL’s former influenza division and the legacy Novartis Influenza Vaccines business. Together the two elevated Seqirus to the second largest influenza company in the world. Seqirus today is a global vaccines leader with one of the broadest influenza vaccine portfolios, and a growing suite of vaccine technologies for COVID-19 and other respiratory pathogens.
CSL Vifor is a strong and rapidly growing presence in nephrology and is committed to launching the next generation of therapies to address the full spectrum of kidney disease, with a focus on dialysis and rare disease. This is supported by their founding heritage and expertise in iron deficiency therapy, helping to support a broad range of patients in need.
RESPONSIBILITIES
The Head, EU PAGA serves as the company’s senior representative with public affairs stakeholders in Brussels. The role is responsible for developing and executing public affairs and stakeholder engagement strategies to achieve the company’s policy objectives with European institutions.
The role will primarily focus on the CSL Behring Business Unit, and will also provide support as needed to the CSL Seqirus and CSL Vifor Business Units.
The person in this role will be responsible for the following:
Develop and lead execution of plans to drive public affairs priorities at the EU level that enable the success of CSL Behring’s business and patient access to our therapies.
Lead and coordinate company engagement with government officials, industry associations, advocacy groups, and other stakeholders, in close cooperation with regional and country team members.
Working closely with International PAGA team colleagues, leads the communication of business-relevant policy updates to senior company leaders; and the development of advocacy materials targeted at EU-level policy makers
Ensure appropriate coordination of public affairs and stakeholder engagement activities at the European level across CSL’s three business units.
QUALIFICATIONS
Graduate/professional degree in law, public health, or similar disciplines preferred.
Minimum 12 years of experience in healthcare policy/public affairs or comparable fields
Experience designing and leading efforts to build company profile and impact with important healthcare public affairs stakeholders in Brussels
Experience collaborating with colleagues at multiple levels of the organization across geographies to align on and execute shared goals
Experience preparing public affairs strategies to maximize success of pipeline assets, including risk identification and mitigation planning
Strong understanding of the workings of major healthcare industry associations in Brussels
Experience partnering with patient groups to advance shared goals
Strong network of relationships with government officials, industry, patient advocacy, and other stakeholders that are influential in Brussels
We encourage you to make your well-being a priority. It’s important and so are you. Learn more about how we care at CSL.
CSL Behring is a global leader in developing and delivering high-quality medicines that treat people with rare and serious diseases. Our treatments offer promise for people in more than 100 countries living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. Learn more about CSL Behring.
As a global organization with employees in 35+ countries, CSL embraces diversity and inclusion. Learn more about Diversity & Inclusion at CSL.
